This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Post, F. A. Articles by Easterbrook, P. J. Search for Related Content PubMed PubMed Citation Articles by Post, F. A. Articles by Easterbrook, P. J. Social Bookmarking                         What's this?

Antiretroviral Therapy in Advanced HIV-1 Infection

Department of HIV/GUM, Guy’s, King’s, King’s College, London

Philippa J. Easterbrook, MD, FRCP

St Thomas’ School of Medicine, King’s College, London

Current recommendations state that antiretroviral therapy (ART) should be commenced before the onset of severe HIV-associated immune deficiency and the development of AIDS-defining infections or malignancies. However, many patients only present and are diagnosed with HIV infection when they already have advanced disease. The optimal treatment for patients with advanced HIV disease remains to be defined. Key management questions include whether the virological and immunological responses to ART are comparable to those seen in patients with less advanced disease; whether the efficacy of different antiretroviral (ARV) regimens differs in patients with advanced disease; and whether there is an increased risk of drug toxicity and the immune reconstitution inflammatory syndrome.

Key Words: HIV/AIDS • advanced disease • highly active antiretroviral therapy

Journal of the International Association of Physicians in AIDS Care (JIAPAC), Vol. 4, No. 1, 8-15 (2005)
DOI: 10.1177/154510970500400102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?